TP53 and cancer: Uddin et al. have explored the dynamic relationship between m6A methylation and drug resistance in cancer cells carrying the p53(R273H) mutation, one of the hot-spot mutations which is found in ∼3.1% of all mutant p53-associated cancers (78).